Therefore, carbon ion therapy may be safer for treating patients with adverse conditions such as large tumors, central tumors, and poor pulmonary function.
First, carbon ion therapy could be safer for treating patients with adverse conditions such as large tumors (e.g., T2), central tumors, or poor lung function.
Carbon ion therapy demonstrates a better dose distribution than SBRT (and even proton therapy) in most cases of early-stage lung cancer; thus, carbon ion therapy may be safer for treating patients with adverse conditions such as large tumors (e.g., T2), central tumors, and poor pulmonary function.
In brief, HDICI immunotherapy is safe for treating childhood malignancies, without causing GVHD.
They concluded that MR guided and thoracoscopic assisted MWA was safe for treating subdiaphragmatic lesions.
An additional factor to take into consideration when using these drugs is that DPP-4 inhibitors (in reduced doses) are safe for treating patients with moderate and severe renal failure, whereas GLP-1 analogs are contraindicated in these patients.
Despite the fact that pulsed US appears to be safe for use in treating experimentally induced infections in rabbits, the same cannot be said for spontaneous infections in humans if US is to be used at infection sites with implants in situ.
Drugs that selectively target ERα or ERβ might be safer for conditions that have been traditionally treated with non-selective estrogens.
Another study showed that NAC was safe for use in Thai patients treated with artesunate (Ref. 176).
Treating wastewater requires a comprehensive planning, design, construction, and management of treatment facilities to ensure that the treated water is safe for human consumption and for discharge to the environment.
